| Identification | |
| Name: | 2-Pentenoic acid,4-[[(2R,5S)-2-[(4-fluorophenyl)methyl]-6-methyl-5-[[(5-methyl-3-isoxazolyl)carbonyl]amino]-1,4-dioxoheptyl]amino]-5-[(3S)-2-oxo-3-pyrrolidinyl]-,ethyl ester, (2E,4S)- |
| Synonyms: | AG 7088;Rupintrivir |
| CAS: | 223537-30-2 |
| Molecular Formula: | C31H39 F N4 O7 |
| Molecular Weight: | 598.6624 |
| InChI: | InChI=1/C31H39FN4O7/c1-5-42-27(38)11-10-24(16-21-12-13-33-29(21)39)34-30(40)22(15-20-6-8-23(32)9-7-20)17-26(37)28(18(2)3)35-31(41)25-14-19(4)43-36-25/h6-11,14,18,21-22,24,28H,5,12-13,15-17H2,1-4H3,(H,33,39)(H,34,40)(H,35,41)/b11-10+/t21-,22+,24+,28-/m0/s1 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.213g/cm3 |
| Refractive index: | 1.537 |
| Usage: | Rupintrivir (formerly AG7088) is an irreversible inhibitor of the human rhinovirus (HRV) 3C protease that has been demonstrated to have in vitro activity against all HRVs tested, consistent with its interaction with a strictly conserved subset of am |
| Safety Data | |
 |
|
